These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1685 related items for PubMed ID: 17460438

  • 1. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S.
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [Abstract] [Full Text] [Related]

  • 2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J, Kim HJ, Ahn SS, Jung SM, Song JJ, Park YB, Lee SW.
    Clin Exp Rheumatol; 2017 Jun; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 4. [New aspects in ANCA-associated vasculitides].
    Lamprecht P.
    Med Klin (Munich); 2004 Sep 15; 99(9):518-22. PubMed ID: 15372181
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, RAVE-ITN Research Group.
    Ann Rheum Dis; 2016 Jun 15; 75(6):1166-9. PubMed ID: 26621483
    [Abstract] [Full Text] [Related]

  • 6. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG.
    J Autoimmun; 2008 Jun 15; 30(1-2):29-36. PubMed ID: 18162369
    [Abstract] [Full Text] [Related]

  • 7. [ANCA-associated vasculitis].
    Sinico RA, Sabadini E, Boeri R, Radice A.
    G Ital Nefrol; 2002 Jun 15; 19(2):125-36. PubMed ID: 12195410
    [Abstract] [Full Text] [Related]

  • 8. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH, Wright MN, Herrmann K, Laudien M, Nölle B, Reinhold-Keller E, Bremer JP, Moosig F, Holle JU.
    Arthritis Rheumatol; 2016 Dec 15; 68(12):2953-2963. PubMed ID: 27333332
    [Abstract] [Full Text] [Related]

  • 9. [Systemic ANCA-associated vasculitis--diagnosis and therapy].
    Eisenberger U, Hess C.
    Ther Umsch; 2008 May 15; 65(5):295-301. PubMed ID: 18622935
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
    Mouthon L.
    Rev Med Interne; 1999 May 15; 20 Suppl 4():431s-435s. PubMed ID: 10522318
    [Abstract] [Full Text] [Related]

  • 11. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D, Jefferson JA.
    Am J Kidney Dis; 2020 Jan 15; 75(1):124-137. PubMed ID: 31358311
    [Abstract] [Full Text] [Related]

  • 12. ANCA Glomerulonephritis and Vasculitis.
    Jennette JC, Nachman PH.
    Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1680-1691. PubMed ID: 28842398
    [Abstract] [Full Text] [Related]

  • 13. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M.
    Arthritis Res Ther; 2005 Oct 06; 7(5):R1072-81. PubMed ID: 16207324
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe.
    Ito-Ihara T, Muso E, Kobayashi S, Uno K, Tamura N, Yamanishi Y, Fukatsu A, Watts RA, Scott DG, Jayne DR, Suzuki K, Hashimoto H.
    Clin Exp Rheumatol; 2008 Oct 06; 26(6):1027-33. PubMed ID: 19210866
    [Abstract] [Full Text] [Related]

  • 15. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
    Bakashvili N, Swaak AJ, Tervaert JW, Dees A.
    Ned Tijdschr Geneeskd; 2008 Apr 26; 152(17):1009-14. PubMed ID: 18549177
    [Abstract] [Full Text] [Related]

  • 16. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU.
    Presse Med; 2013 Apr 26; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides.
    Reinhold-Keller E.
    Curr Pharm Des; 2012 Apr 26; 18(29):4537-41. PubMed ID: 22612757
    [Abstract] [Full Text] [Related]

  • 18. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K, Mandell BF.
    Postgrad Med; 2023 Jan 26; 135(sup1):3-13. PubMed ID: 35831990
    [Abstract] [Full Text] [Related]

  • 19. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.
    Nephrol Dial Transplant; 2016 Sep 26; 31(9):1453-9. PubMed ID: 27242368
    [Abstract] [Full Text] [Related]

  • 20. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M, Kallenberg CG.
    Clin Exp Rheumatol; 2009 Sep 26; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 85.